Extra intravenous Ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn’s disease

Extra intravenous Ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn’s disease

ObjectivesUstekinumab (UST) optimization strategies, including shortening intervals and intravenous reinduction, should be administered to patients with partial or loss of respond. Evidence comparing these types of optimization treatments is limited. We evaluated the efficacy and safety of weight-ba...

Full description

Bibliographic Details
Main Authors: Jiayin Yao, Xiang Peng, Yingkui Zhong, Tao Su, Adam Bihi, Junzhang Zhao, Tao Liu, Wei Wang, Pinjin Hu, Min Zhang, Min Zhi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Medicine
Subjects:
Crohn’s disease
Ustekinumab
optimization algorithm
intravenous reinduction
endoscopic remission
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1105981/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1105981/full

Similar Items